Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Womens Health Phys Therap. 2014 Sep;38(3):118–124. doi: 10.1097/JWH.0000000000000020

Shoulder impairment before breast cancer surgery

Ann Marie Flores (1), Kathleen Dwyer (2)
PMCID: PMC4290873  NIHMSID: NIHMS633311  PMID: 25593563

Abstract

Objective

To compare pre- and post-operative shoulder active range of motion (AROM) values from female breast cancer survivors to population norm values for shoulder AROM; and to compare shoulder AROM differences pre- and post-surgery between female African American and White breast cancer survivors (BCA).

Study design

This pilot study used a convenience sample and longitudinal design measuring participants 2 times (T0 = baseline, after biopsy but within 2 weeks before BCA surgery; T1 = 2nd postoperative week).

Background

The U.S. has the largest BCA survivor population in history and yet the mortality burden remains highest among AA BCA survivors. AAs may also have greater burden of physical and functional side effects compared to whites and the general population.

Methods and Measures

The data were collected from a convenience sample (n = 33; nAA = 9, nW = 24) and included data on shoulder AROM, medical chart review for pre- and co-morbid conditions, and self-reported demographics and medical history. We used t-tests to compare sample AROM means to population norms. We then compared our sample across 2 timepoints (T0 = pre-surgery; T1 = 2 weeks post-surgery) using independent samples t-tests and repeated measures analysis of variance (p < .05) to compare AA to White sub-samples AROM means.

Results

African Americans had significantly less shoulder abduction (at T0) and flexion (at T1) than whites. However, 100% had significantly reduced AROM for all movements at T0 (prior to surgery but after biopsy) when compared to population norms.

Conclusions

The significant reduction in shoulder AROM after biopsy but before surgery points to a possible unmet need for early physical therapy intervention. Further research using randomized controlled trial design is recommended.

Keywords: breast cancer, physical therapy, shoulder range of motion, cancer survivorship

INTRODUCTION

Females with breast cancer (BCA) constitute 22% of the 13.7 million U.S. cancer survivors and 41% of female cancer survivors1 More people are living with side effects of cancer and its treatment than ever before, with 4.1 million in 20072 which is expected to exceed 18 million by 2020.3

While we know a great deal about incidence, prevalence and mortality of breast cancer, we know very little about the BCA survivorship experience in terms of physical impairments prior to curative treatment and survivorship experiences of minorities. The literature on BCA survivorship is largely confined to those who are at least a year after completion of acute treatment (e.g. surgery, radiation, chemotherapy).2,4,5

Women who have had BCA surgery, especially those with mastectomy followed by radiation and chemotherapy16, report impaired joint range of motion, fatigue, pain, and alteration in activities of daily living and self-perceived function.417 Few studies include minority women and none have examined physical impairment for minorities between the time of diagnostic biopsy and surgery.1821 AROM generally decreases after BCA surgery, especially status-post mastectomy with or without reconstruction.1822 Continued impairment without intervention can interfere with function to the point of disability.23 Twenty percent of BCA survivors report some sort of physical limitation and many ranked this as a number one concern.18 Among those with axillary dissection, at least 12% reported a significant loss of range of motion and half reported pain and/or loss of strength regardless of type of surgery (breast conservation or mastectomy) and time since surgery.22 Cancer treatment-related surgical resection of muscle, lymph nodes and nerves; pain, lymphedema,611,14,22,24 fatigue and weight gain or loss are also important factors moderating the extent of ROM loss.17,25 Radiation desquamation, tissue fibrosis, axillary web syndrome, and chest wall adhesions also limit range of motion.7,26 In the case of mastectomy, the breast is removed and, often, a small amount of muscle tissue is removed to obtain disease-free surgical margins.4,21,27 Natural tissue reconstructive surgeries involve muscle relocation from a breast mound leaving a shoulder girdle muscle imbalance.28 Sentinel lymph node biopsy may be followed by additional dissection and be just as invasive as an axillary dissection.12,14,29,30 This too contributes to altered shoulder mechanics and lymph drainage.1214,3133 Reliance on large muscles (lattisimus dorsi, trapezius) place considerable torque on the shoulder leading to bursitis, tendonitis, adhesive capsulitis, or premature osteoarthritic changes all of which can reduce ROM.27,34 Compensation by smaller muscles (teres major and minor, supraspinatus, infraspinatus, subscapularis, rhomboideous major and minor muscles, and the serratus anterior)35 can also create a situation of overuse, muscle fatigue and spasm. This can be compounded by poor posture and pain creating a vicious cycle of limited movement, pain and reductions in strength due to disuse.7

The time between BCA biopsy and pathology results is anxiety provoking but also presumed to be free of cancer-related physical impairment. However, this may also be a time when a reduction in AROM occurs because of guarding of the biopsy site and biopsy- related pain, albeit less invasive than surgery. In support of, and extending previous work, it was hypothesized that not only is shoulder ROM reduced on the involved side after surgery, but that it may also be reduced even prior to surgery as compared to normal population values. While post-surgical AROM limitation is clearly linked to surgical intervention and recovery, no evidence exists to support or refute whether limitation in AROM is detected prior to surgery in otherwise healthy individuals without a medical history of pathology that could affect shoulder range of motion (e.g.: diabetic shoulder).

In addition to the possibility of early presentation of AROM reduction, few studies of minority BCA survivors consider differences in physical impairment as most studies focused on incidence, prevalence and mortality.19,20,3739 Minorities and the poor and medically underserved experience cancer disparities.4050 However, cancer survivorship disparities is a new area of research.20,51,52 Biomechanical and structural changes (e.g. range of motion, strength, removal or re-attachment of muscle, transection of motor or sensory nerves and lymphedema) are not described or cited as possible underlying causes of physical limitations or disability in the BCA survivorship literature.

With the exception of a small handful of studies18,19,20,53 there is a dearth of published research examining disparities in function and ROM after cancer. AA BCA survivors report lower physical functioning than whites using self-report measures.53 Long-term self-reported function is worse in those who have had mastectomy and combined chemotherapy and radiation persisting 5 years after diagnosis.18 With few exceptions19,20 self-report measures are used to represent AROM. It can be argued that disparities related to BCA incidence, prevalence and mortality may also place minorities at greater risk for developing disability. No studies have examined the combination of range of motion prior to curative treatment and disparities in physical impairment. The aim of this investigation was to fill that gap and this study was the first to examine this possibility. The objectives of this pilot study were to compare 1) pre- and post-operative shoulder AROM values from female BCA survivors to population norm values for shoulder AROM; 2) shoulder AROM differences pre- and post-surgery between female AA and white BCA survivors.

METHODS & MEASURES

This pilot study utilized a prospective, repeated measures design comparing data from a convenience sample of women with BCA. Each participant reviewed and signed an Institutional Review Board approved informed consent document. Three study staff members (the PI and 2 research assistants trained on the protocol) collected all data for the study. The participants completed a survey of sociodemographic characteristics and relevant medical history information. Medical history information obtained from the survey was verified using information from the participant’s medical chart. Participants agreed to be measured for AROM one to two weeks prior to surgery (coinciding with the pre-operative testing appointment) and again approximately two to three weeks after surgery to ensure removal of surgical drains for those participants who were status-post mastectomy. Active range of motion was measured with a two-armed twelve-inch goniometer according to the guidelines described by Norkin and White.35 Specifically, all measurements were taken in the supine position, except for shoulder extension which was measured in a supported, seated position with normal postural alignment. Normal population values for each range of motion were used to compare our sample data to the population. The population data were derived from the American Academy of Orthopaedic Surgeons.54 For shoulder flexion, the normal range for flexion was 180 degrees, and the normal ranges for extension, abduction internal rotation and external rotation were 60, 70, 70 and 90 degrees, respectively. Inter- and intra-rater reliability were tested for all study staff on normals prior to the study using the same protocol procedure (each motion measured 3 times and then averaged). The ICCs for each motion were high (ICC=.90) for all study staff.

Participants had their active range of motion measured for shoulder flexion, extension, abduction, internal and external rotation and were instructed to move only in the pain free range. All motions were first demonstrated by trained study staff. The participants were asked to move the involved and uninvolved shoulder in each range three times. The measures for each range were then averaged for each measurement time on the involved side.

To evaluate the first objective, a t-test was conducted comparing sample means prior to BCA surgery to normal population values for each range of motion (p<.05) at T0 and T1. To address the second objective, the differences between T0 (prior to surgery) to T1 (two – three weeks after surgery) were compared to the entire sample using one-tailed independent t-tests (p < .05). Next, the differences between AA and white BCA survivors between T0 and T1 were evaluated using a repeated measures ANOVA. Since only two groups were compared, post-hoc testing was not pursued. All analyses were performed with SPSS version 17.0 (SPSS Inc. Chicago, IL).

RESULTS

All participants had T0 measures taken within 2 weeks of their scheduled breast cancer surgery and most (95%) were measured 1 week prior to surgery. All T0 measures coincided with pre-operative testing appointments. All but 1 participant had T1 measures taken within 2 weeks. This participant had her drains removed at post-operative week 2.5.

Descriptive characteristics

Table 1 presents the descriptive characteristics for the sample. Thirty-three BCA survivors participated in the study (24 White; 9 AA). On average, participants were 55 years old with at least one year of college. Fifty percent of the overall sample reported annual household incomes of $50k or more per year. Five participants (15%) reported annual household income of less than ten thousand dollars. Of these five participants with annual household incomes of less than $15k, 60 percent were African American. The opposite was true for Whites in that 66 percent of these participants reported annual household incomes of at least $35k.

Table 1.

Descriptive Characteristics of BCA Survivors.

All
n=33
AA
n=9
White
n=24
Mean (SD) Age in years 55 (1.9) 56 (2.9) 53 (1.4)
Household Income
 < $10,000 5 3 2
 $10,000 – $14,999 4 2 2
 $15,000 – $24,999 1 0 1
 $25,000 – $34,999 3 0 3
 $35,000 – $49,999 2 1 1
 $50,000 – $74,000 3 0 3
 $75,000 – $99,999 3 1 2
 $100,000 – $149,999 4 0 4
 $150,000 – $199,999 2 0 2
 ≥ $200k 1 0 1
 Refused to answer/missing 5 2 3
Mean (SD) Years of Education 14 (.4) 13 (.8) 14 (2.5)*
Type of BCA Surgery
 # Lumpectomy 23 6 17
 # Unilateral Mastectomy (modified radical or radical) 4 1 3
 # Bilateral Mastectomy or Unilateral Radical Mastectomy 2 0 2
 Don’t Know 4 2 2
*

p<.05, independent samples t-test

Two thirds had breast conservation (lumpectomy) surgery. Fourteen percent of the total sample did not know what type of surgery they had. Twenty two percent of the African American sub-sample could not name and did not know what type of surgery they had. This percentage was smaller for Whites (8.3%).

Range of Motion – Overall Sample

Table 2 compares sample averages to population norms for shoulder range of motion. With the exception of shoulder extension and internal rotation prior to surgery, all participants had shoulder ranges of motion that were statistically significantly lower than the population norms after diagnostic biopsy, but before surgical intervention. One participant had a history of a partial rotator cuff tear contralateral to the breast cancer site. When this participant’s data were excluded from the analyses, the results were no different than when the data were included.

Table 2.

Mean (s.d.) shoulder AROM in degrees

Normal AROM T0
n=26
T1
n=25
Flexion 180 151* (9.1) 105* (11.1)
Extension 60 58 (5.4) 37* (3.9)
Abduction 180 144* (8.4) 83* (10.1)
Internal Rotation 65 64 (3.5) 59 (6.5)
External Rotation 90 76* (3.9) 52* (6.0)
*

p<.05, t-test comparing to normal values

As expected, all involved shoulder ranges of motion were statistically significantly reduced compared to normal population values at T1. The uninvolved side did not significantly differ from population norms.

Range of Motion Disparities

Table 3 shows that AAs had significantly reduced active shoulder abduction on the involved side prior to surgery compared to Whites (120 versus 161 degrees, a 41 degree difference between the groups [p <.05; one tailed test]). In order to receive radiation treatment, 120 degrees of range of motion is required for axillary radiation.35 At T1 (2 weeks after surgery) every participant experienced reduced shoulder abduction. However, AA particpants had significantly reduced shoulder flexion when compared to Whites (90 versus 110 degrees). In no case did the White sub sample have a significantly lower range of motion than AAs for any of the shoulder movements prior to or after surgery.

Table 3.

Mean shoulder AROM in degrees for AA and whites compared to norms**

Normal AROM T0 T1
AA
(n=7)
White
(n=19)
AA
(n=7)
White
(n=19)
Flexion 180 158* (9.6) 157* (9.5) 90*, (19.8) 110* (13.4)
Extension 60 72* (15.5) 56* (3.69) 35* (7.5) 37* (4.7)
Abduction 180 120*, (16.4) 161* (3.93) 80* (16.6) 85* (12.7)
Internal Rotation 65 63 (5.5) 68 (2.78) 63 (13.2) 59 (7.5)
External Rotation 90 77* (4.7) 80 (2.95) 48* (10.7) 54* (7.4)
**

For participants with complete data at T0 & T1; nAA=7, nwhite=19

*

p<.05, single sample t-test (comparing T0 to normal values)

p<.05; Repeated measures ANOVA; 1-tailed t-test (comparing AA & whites)

DISCUSSION

All participants in this pilot study demonstrated active shoulder range of motion limitations (flexion, abduction, and external rotation) that were significantly lower than normal population values, despite the fact that none of the participants had any significant co-morbidities that may be associated with shoulder impairment. This difference was greatest for the African American participants. These findings hold important implications for clinical practice and identification of the candidates for physical therapy. McNeely55 and Shamley et al56 showed support for delayed exercise interventions after BCA surgery to reduce the risk of seroma formation, improve mood, and anxiety, yet none of these studies looked at dysfunction prior to surgery. Silver suggested that rehabilitation for breast cancer survivors has a great deal to offer in terms of improving strengthening, cardiac endurance, pain and fatigue that has been shown to occur due to cancer treatment.29 Additional research shows that exercise, including resistance exercise, is critical to the management of lymphedema.17,57 These pilot data suggest early and significant shoulder impairment may be present after biopsy and before surgery for curative intent. Early intervention/prospective surveillance of lymphedema beginning with pre-operative surgical pathways has been shown to be an effective and cost-savings approach.58 The findings of this investigation provide further support to the prospective surveillance approach.

This pilot study is particularly timely because the effects of exercise prior to curative treatment have not yet been studied despite evidence that exercise has preventive effects on first time cancer diagnosis and recurrence.42,59,60 Exercise has also been shown to be associated with improved quality of life for up to 10 years after treatment.61 Exercise has also been shown to decrease fatigue, and improve cardiovascular endurance, physical function,16,55,6265 and symptom management.66 Currently, none of the exercise protocols rigorously tested with RCTs have been translated into the standard of care.6770 Early identification of shoulder impairment may be an even more critical issue for AA BCA survivors. Satariano and colleagues have already shown that AA BCA survivors report more functional limitation and impaired self-reported shoulder range of motion than Whites.1920 The present study used precise clinical goniometric measurements, and provides preliminary evidence that health disparities in BCA survivorship may exist in terms of physical impairments.

Clinically speaking, baseline shoulder AROM of BCA patients is presumed to be normal prior to surgical intervention, with the exception of those with pre-existing shoulder impairments. In the case of this study sample, none of the participants had pre-existing conditions that are associated with shoulder dysfunction. Considering that the natural course of recovery from BCA surgery has a time period of expected shoulder range of motion reduction, the combination of a pre-morbid reduction in shoulder range of motion, along with the reduction necessitated by surgery and postoperative precautions (especially for mastectomy procedures71), can have a large negative impact on the functional ability making things as simple as hugging, brushing one’s hair, putting on a seat belt, or reaching in overhead cabinets problematic. As with any pilot study, the small sample size poses limitations on the generalizability of results. However, the results preliminarily suggest that physical and functional recovery after breast cancer may be another source of disparities in cancer care.

There may be a variety of other reasons for the reduction in shoulder range of motion prior to surgical intervention. First, it is quite possible that the participant had reduced active shoulder range of motion prior to the diagnostic procedures. However when the medical chart review data were examined, only one participant had a history that would indicate a possible shoulder impairment or condition associated with shoulder involvement (e.g.: history of rotator cuff tear more than 5 years prior to the study on the contralateral side of the breast cancer surgery). When excluded this case was excluded from the analyses, the results were unchanged. It is also possible that these reductions may be related to the aging process.72,73 Considering that this study based comparisons to normal population values across the age spectrum, and that the sub-samples were similar in age, the possibility that aging may play a role was limited. A plausible third reason was that muscle guarding of the involved side may overflow to guarding on the uninvolved side. While data were not collected on muscle guarding, some of the participants related that they were “favoring” the involved side.

The present study was the first to provide clinical measures suggesting that AAs may be disadvantaged in terms of objective physical impairment before formal cancer treatment begins. AA BCA survivors have been reported as having lower levels of functional quality of life than Whites, which has been attributed to age and income but not necessarily shoulder AROM.18 In this study, AA participants comprised the majority of BCA survivors with household incomes of less than $15k. This too may have confounded the results in that impoverished individuals may be at greater risk of physical impairment than those with greater financial resources, as is the case with mortality and other sources of disparities.49,50,74,75 We recognize that the AA sub-sample was smaller than the White sub-sample. However, our AA BCA survivors comprised 27% of the entire sample – a sizeable amount compared to the previously mentioned studies.49,50,74,75 With larger and comparable sample sizes, it may be able to better detect whether disparities in physical impairment exist by income status and/or race.74

The most dramatic difference prior to surgery was for shoulder abduction. Most movement requires combined planes of movement especially in the shoulder in order to accomplish independent activities of daily living such as those described earlier. This pilot study points to a possibility that shoulder range of motion may need to be addressed in the pre-surgical phase, particularly for AA BCA survivors.

An important strength of this study was that nearly thirty percent of the sample was African American. The AA and White sub-samples were comparable in terms of age and surgical type. Another strength of the study was the ability to recruit participants prior to surgery and usually within one week after the biopsy procedure. This required a great deal of coordination and close communication with community physicians and their clinic staff. As such, the team was careful to cultivate mutual trust and respect by community physicians and leaders in the local AA and BCA communities served by community hospitals, physician practices and a local comprehensive cancer center. This study had a relatively small sample but plans are underway to expand this project to include longitudinal data collection and randomization with a larger sample and more minority group representation.

CONCLUSIONS

In summary, this was the first study to prospectively examine range of motion prior to surgical intervention for breast cancer survivors. All participants had active shoulder range of motion limitations (flexion, abduction, and external rotation) that were significantly reduced from normal population values despite the fact that none of the participants had any significant co-morbidities that could sufficiently explain the differences. The significant reduction in active shoulder range of motion prior to surgery but after biopsy points to a potential cause of physical limitation for breast cancer survivors that may merit early physical therapy intervention. This merits further study. Of noted importance is that range of motion limitation was greatest for African American participants which comprised nearly thirty percent of the sample. Limitations in physical function may be worse for African American breast cancer survivors and this may contribute to increased cancer related burden during the survivorship phase. Despite the limitations of this study (i.e.: small sample size, lack of randomization, case-control comparisons, and longitudinal measures), this pilot project points to important avenues to explore for physical and functional recovery after breast cancer surgery.

Acknowledgments

Acknowledgment of funding: This study was supported in part by NIH grants U54CA091408, P20 MD000516, and UL 1RR024975. We are grateful to Britney Hagy and Leah Watson for assistance with data collection.

References

  • 1.Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012 Jul-Aug;62(4):220–41. doi: 10.3322/caac.21149. [DOI] [PubMed] [Google Scholar]
  • 2.Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2007. National Cancer Institute; Bethesda, MD: 2010. http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site. [Google Scholar]
  • 3.Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):1996–2005. doi: 10.1158/1055-9965.EPI-11-0729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cleeland CS, Gonin R, Hatfield RK, Edmonson JH, Blum RH, Stewart AK, Pandya JK. Pain and its treatment in outpatients with metastatic cancer. New England Journal of Medicine. 1994;330:392–396. doi: 10.1056/NEJM199403033300902. [DOI] [PubMed] [Google Scholar]
  • 5.Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008;(2):CD006145. doi: 10.1002/14651858.CD006145.pub2. [DOI] [PubMed] [Google Scholar]
  • 6.Amichetti M, Caffo O. Pain after quadranectomy and radiotherapy for early-stage breast cancer: incidence, characteristics and influence on quality of life: Results from a retrospective study. Oncology. 2003;65(1):23–8. doi: 10.1159/000071201. [DOI] [PubMed] [Google Scholar]
  • 7.Carpenter JS, Sloan P, Andrykowski MA, McGrath P, Sloan D, Rexford T, Kenady D. Risk factors for pain after mastectomy/lumpectomy. Cancer Practice. 1999;7(2):66–70. doi: 10.1046/j.1523-5394.1999.07208.x. [DOI] [PubMed] [Google Scholar]
  • 8.Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104(1–2):1–13. doi: 10.1016/s0304-3959(03)00241-0. [DOI] [PubMed] [Google Scholar]
  • 9.Flores AM, Hodges LC, Brewer LH. Recovering shoulder function and quality of life after breast cancer surgery. Journal of the Section of Women’s Health. 2004;28:7–14. [Google Scholar]
  • 10.Kärki A, Simonen R, Mälkiä E, Selfe J. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med. 2005 May;37(3):180–8. doi: 10.1080/16501970410024181. [DOI] [PubMed] [Google Scholar]
  • 11.Kuehn T. Long-term morbidity following axillary dissection in breast cancer patients – clinical assessment, significance for life qualitiy and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275–286. doi: 10.1023/a:1026564723698. [DOI] [PubMed] [Google Scholar]
  • 12.Rietman JS, Dijkstra PU, Debreczeni R, et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004;26:78–84. doi: 10.1080/09638280310001629642. [DOI] [PubMed] [Google Scholar]
  • 13.Rietman JS, Dijkstra PU, Geertzent JHB, et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol. 2004;11:1018–1024. doi: 10.1245/ASO.2004.03.512. [DOI] [PubMed] [Google Scholar]
  • 14.Rietman JS, Geertzen JH, Hoekstra HJ, et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. European Journal of Surgical Oncology. 2006;32(2):148–52. doi: 10.1016/j.ejso.2005.11.008. [DOI] [PubMed] [Google Scholar]
  • 15.Macdonald L, Bruce J, Scott NW, Smith WC, Chambers Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer. 2005 Jan 31;92(2):225–30. doi: 10.1038/sj.bjc.6602304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Schwartz AL, Mori M, Gao R, Nail LM, King ME. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc. 2001;33:718–723. doi: 10.1097/00005768-200105000-00006. [DOI] [PubMed] [Google Scholar]
  • 17.Schmitz KH, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009;361(7):664–73. doi: 10.1056/NEJMoa0810118. [DOI] [PubMed] [Google Scholar]
  • 18.Ganz PA, Desmond KA, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002 Jan 2;94(1):39–49. doi: 10.1093/jnci/94.1.39. [DOI] [PubMed] [Google Scholar]
  • 19.Satariano WA, DeLorenze GN. The likelihood of returning to work after breast cancer. Public Health Reports. 1996;111(3):242–3. [PMC free article] [PubMed] [Google Scholar]
  • 20.Satariano WA, Ragland DR, DeLorenze GN. Limitations in upper-body strength associated with breast cancer: a comparison of black and white women. J Clin Epi. 1996;49(5):535–44. doi: 10.1016/0895-4356(95)00565-x. [DOI] [PubMed] [Google Scholar]
  • 21.Voogd AC, Ververs JM, Vingerhoets AJ, et al. Lymphedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. The British Journal of Surgery. 2003;90(1):76–81. doi: 10.1002/bjs.4010. [DOI] [PubMed] [Google Scholar]
  • 22.Ernst MF, Voogd AC, Balder W, Klinkinbijl JHG, Roukema JA. Early & late morbidity associated with axillary levels I –III dissection in breast cancer. J Surg Onc. 2002;79:151–155. doi: 10.1002/jso.10061. [DOI] [PubMed] [Google Scholar]
  • 23.World Health Organization. Towards a common language for functioning, disability, and health: ICF. World Health Organization; Geneva, Switzerland: 2002. [Google Scholar]
  • 24.Kakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI. Objective assessment of axillary morbidity in breast cancer treatment. The American Surgeon. 1999;65(10):995–8. [PubMed] [Google Scholar]
  • 25.Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005 Nov;13(11):904–11. doi: 10.1007/s00520-005-0810-y. [DOI] [PubMed] [Google Scholar]
  • 26.Vecht CJ. Arm pain in the patient with breast cancer. J Pain Symptom Management. 1990;5:109–17. doi: 10.1016/s0885-3924(05)80024-7. [DOI] [PubMed] [Google Scholar]
  • 27.Sahrmann S. Diagnosis and Treatment of Movement Impairment Syndromes. Mosby Inc; Aug, 200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hu E, Alderman AK. Breast reconstruction. Surg Clin North Am. 2007 Apr;87(2):453–67. doi: 10.1016/j.suc.2007.01.004. [DOI] [PubMed] [Google Scholar]
  • 29.Silver JK. Rehabilitation in women with breast cancer. Phys Med Rehabil Clin N Am. 2007 Aug;18(3):521–37. doi: 10.1016/j.pmr.2007.05.003. [DOI] [PubMed] [Google Scholar]
  • 30.Haid A, Köberle-Wührer R, Knauer M, et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat. 2002;73:31–36. doi: 10.1023/a:1015234318582. [DOI] [PubMed] [Google Scholar]
  • 31.Ronka R, von Smitten K, Tasmuth T, Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast. 2005;14:28–36. doi: 10.1016/j.breast.2004.09.010. [DOI] [PubMed] [Google Scholar]
  • 32.Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol. 2006;93:109–119. doi: 10.1002/jso.20406. [DOI] [PubMed] [Google Scholar]
  • 33.Deutsch M, Flickinger JC. Shoulder and arm problems after radiotherapy for primary breast cancer. Am J Clin Oncol. 2001;24:172–176. doi: 10.1097/00000421-200104000-00015. [DOI] [PubMed] [Google Scholar]
  • 34.Levangie PK, Norkin CC. Joint Structure and Function: A Comprehensive Analysis. 4. FA Davis Co; Philadelphia, PA: 2005. p. 19103. [Google Scholar]
  • 35.Norkin CC, White DJ. Measurement of joint motion, a guide to goniometry. Philadelphia: FA Davis; 2003. p. 3. [Google Scholar]
  • 36.American Physical Therapy Association. Guide to Physical Therapist Practice, Revised. 2. Alexandria, VA: 2002. [Google Scholar]
  • 37.Shimozuma K, Ganz PA, Petersen L, Hirji K. Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Research and Treatment. 1999;56:45–57. doi: 10.1023/a:1006214830854. [DOI] [PubMed] [Google Scholar]
  • 38.Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:97:134–97. doi: 10.1002/cncr.11051. [DOI] [PubMed] [Google Scholar]
  • 39.Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57. doi: 10.1093/jnci/94.5.334. [DOI] [PubMed] [Google Scholar]
  • 40.Anderson KO, Mendoza TR, Payne R, et al. Pain education for underserved minority cancer patients: a randomized controlled trial. Journal of clinical oncology. 2004;22(24):4918–25. doi: 10.1200/JCO.2004.06.115. [DOI] [PubMed] [Google Scholar]
  • 41.Anderson KO, Mendoza TR, Valero V, et al. Minority cancer patients and their providers: pain management attitudes and practice. Cancer. 2000;88(8):1929–38. [PubMed] [Google Scholar]
  • 42.Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005 Mar 16;97(6):439–48. doi: 10.1093/jnci/dji064. [DOI] [PubMed] [Google Scholar]
  • 43.Commisky P, Baquet C. Socioeconomic factors and breast carcinoma in multicultural women. Cancer. 2000;1:88(5 Suppl):1256–64. doi: 10.1002/(sici)1097-0142(20000301)88:5+<1256::aid-cncr13>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  • 44.Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities. Arch Intern Med. 2002;162:1885–1993. doi: 10.1001/archinte.162.17.1985. [DOI] [PubMed] [Google Scholar]
  • 45.Kolb B, Wallace AM, Hill D, Royce M. Disparities in cancer care among racial and ethnic minorities. Oncology (Williston Park) 2006 Sep;20(10):1256–61. discussion 1261, 1265, 1268–70. [PubMed] [Google Scholar]
  • 46.Polacek GN, Ramos MC, Ferrer RL. Breast cancer disparities and decision-making among U.S. women. Patient Educ Couns. 2007 Feb;65(2):158–65. doi: 10.1016/j.pec.2006.06.003. [DOI] [PubMed] [Google Scholar]
  • 47.Li CI. Ethn Dis. 2 Suppl 2. Vol. 15. Spring; 2005. Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States; pp. S5–9. [PubMed] [Google Scholar]
  • 48.LaVeist TA. Disentangling race and socioeconomic status: a key to understanding health inequalities. Urban Health. 2005 Jun;82(2 Suppl 3):iii26–34. doi: 10.1093/jurban/jti061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Freeman HP. Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin. 2004 Mar-Apr;54(2):72–7. doi: 10.3322/canjclin.54.2.72. [DOI] [PubMed] [Google Scholar]
  • 50.Freeman HP. The meaning of race in science--considerations for cancer research: concerns of special populations in the National Cancer Program. Cancer. 1998 Jan 1;82(1):219–25. doi: 10.1002/(sici)1097-0142(19980101)82:1<219::aid-cncr27>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  • 51.Alderman AK, Hawley ST, Janz NK, et al. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population-based study. J Clin Oncol. 2009 Nov 10;27(32):5325–30. doi: 10.1200/JCO.2009.22.2455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Sehl ME, Satariano WA, Ragland DR, Reuben DB, Naeim A. Attribution of functional limitation to cancer decreases in the year following breast cancer diagnosis in older patients. Crit Rev Oncol Hematol. 2009 Jul;71(1):62–9. doi: 10.1016/j.critrevonc.2008.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Bowen DJ, Alfano CM, McGregor BA, et al. Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat. 2007 Jan 27; doi: 10.1007/s10549-006-9479-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.American Academy of Orthopaedic Surgeons. Joint motion: method of measuring and recording. New York, NY: Churchill Livingstone; 1988. [Google Scholar]
  • 55.McNeely ML, Campbell KL, Rowe BH, et al. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006;175:34–41. doi: 10.1503/cmaj.051073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat. 2005;90:263–271. doi: 10.1007/s10549-004-4727-9. [DOI] [PubMed] [Google Scholar]
  • 57.Paramanandam VS, Roberts D. Weight training is not harmful for women with breast cancer-related lymphedema: a systematic review. J Physiother. 2014 Sep;60(3):136–43. doi: 10.1016/j.jphys.2014.07.001. [DOI] [PubMed] [Google Scholar]
  • 58.Stout NL, Pfalzer LA, Springer B, et al. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012 Jan;92(1):152–63. doi: 10.2522/ptj.20100167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Matthews CE, Shu XO, Jin F, et al. Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer. 2001 Apr 6;84(7):994–1001. doi: 10.1054/bjoc.2000.1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Caan BJ, Emond JA, Natarajan L, et al. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006;99:47–57. doi: 10.1007/s10549-006-9179-y. [DOI] [PubMed] [Google Scholar]
  • 61.Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L. Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res. 2005 Mar;14(2):361–71. doi: 10.1007/s11136-004-1468-5. [DOI] [PubMed] [Google Scholar]
  • 62.Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum. 1997;24:991–1000. [PubMed] [Google Scholar]
  • 63.Mock V, Pickett M, Ropka ME, et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract. 2001;9:119–127. doi: 10.1046/j.1523-5394.2001.009003119.x. [DOI] [PubMed] [Google Scholar]
  • 64.Segal R, Evans W, Johnson D, et al. Structured exercise improves physical functioning in women with Stage I and II breast cancer: results of a randomized controlled trial. J Clin Oncol. 2001;19:657–665. doi: 10.1200/JCO.2001.19.3.657. [DOI] [PubMed] [Google Scholar]
  • 65.Couneya KS, Mackey JR, Bell GJ, et al. Randomized controlled trial of exercise in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21:1660–1668. doi: 10.1200/JCO.2003.04.093. [DOI] [PubMed] [Google Scholar]
  • 66.Oldervoll LM, Loge JH, Paltiel H, et al. The effect of a physical exercise program in palliative care: a Phase II study. J Pain Symptom Manage. 2006;31:421–430. doi: 10.1016/j.jpainsymman.2005.10.004. [DOI] [PubMed] [Google Scholar]
  • 67.Phillips SM, Alfano CM, Perna FM, Glasgow RE. Accelerating translation of physical activity and cancer survivorship research into practice: recommendations for a more integrated and collaborative approach. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):687–99. doi: 10.1158/1055-9965.EPI-13-1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Jones LW, Eves ND, Peddle CJ, et al. Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions. Appl Physiol Nutr Metab. 2009 Apr;34(2):197–202. doi: 10.1139/H08-104. [DOI] [PubMed] [Google Scholar]
  • 69.Rodriguez-Larrad A, Lascurain-Aguirrebena I, Abecia-Inchaurregui LC, Seco J. Perioperative physiotherapy in patients undergoing lung cancer resection. Interact Cardiovasc Thorac Surg. 2014 May 12; doi: 10.1093/icvts/ivu126. [DOI] [PubMed] [Google Scholar]
  • 70.Peddle CJ, Jones LW, Eves ND, et al. Correlates of adherence to supervised exercise in patients awaiting surgical removal of malignant lung lesions: results of a pilot study. Oncol Nurs Forum. 2009 May;36(3):287–95. doi: 10.1188/09.ONF.287-295. [DOI] [PubMed] [Google Scholar]
  • 71.Lauridesen MC, Christiansen P, Hessov IB. The effects of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol. 2005;44:449–457. doi: 10.1080/02841860510029905. [DOI] [PubMed] [Google Scholar]
  • 72.Garman KS, Pieper CF, Seo P, Cohen HJ. Function in elderly cancer survivors depends on comorbidities. The Journals of Gerontology. 2003 Dec;58(12):M1119–24. doi: 10.1093/gerona/58.12.m1119. [DOI] [PubMed] [Google Scholar]
  • 73.Sweeney C, Schmitz KH, Lazovich D, et al. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst. 2006;98:521–529. doi: 10.1093/jnci/djj130. [DOI] [PubMed] [Google Scholar]
  • 74.Yoon J, Malin JL, Tisnado DM, et al. Symptom management after breast cancer treatment: is it influenced by patient characteristics? Breast Cancer Res Treat. 2007 Jul 19; doi: 10.1007/s10549-007-9580-1. [DOI] [PubMed] [Google Scholar]
  • 75.Gregory PC, LaVeist TA, Simpson C. Racial disparities in access to cardiac rehabilitation. Am J Phys Med Rehabil. 2006 Sep;85(9):705–10. doi: 10.1097/01.phm.0000233181.34999.3d. [DOI] [PubMed] [Google Scholar]

RESOURCES